Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?

The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC). The study included 55 patients with metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordu, Cetin, Selcuk, Nalan A., Erdogan, Ezgi, Angin, Gulden, Gural, Zeynep, Memis, Hatice, Yencilek, Esin, Dalsuna, Sinem, Pilanci, Kezban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603106/
https://www.ncbi.nlm.nih.gov/pubmed/25526475
http://dx.doi.org/10.1097/MD.0000000000000299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603106/
https://www.ncbi.nlm.nih.gov/pubmed/25526475
http://dx.doi.org/10.1097/MD.0000000000000299

Ejemplares similares